Fatty acid amide hydrolase deficiency limits early pregnancy events

Journal of Clinical Investigation

Volumn 116, Issue 8, 2006, Pages 2122-2131

  Wang, Haibin ^a   Xie, Huirong ^a   Guo, Yong ^a   Zhang, Hao ^a   Takahashi, Toshifumi ^a   Kingsley, Philip J ^b   Marnett, Lawrence J ^b   Das, Sanjoy K ^a,b   Cravatt, Benjamin F ^c   Dey, Sudhansu K ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID; ENDOCANNABINOID; FATTY ACID AMIDASE; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHOLIPASE D; TRANSCRIPTION FACTOR CDX2;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME DEFICIENCY; ENZYME DEGRADATION; ENZYME INACTIVATION; ENZYME SYNTHESIS; EVIDENCE BASED MEDICINE; FIRST TRIMESTER PREGNANCY; GROWTH RETARDATION; MOUSE; NIDATION; NONHUMAN; OVIDUCT; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUBFERTILITY;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; DISEASE MODELS, ANIMAL; FALLOPIAN TUBES; FEMALE; MICE; MICE, INBRED C57BL; POLYUNSATURATED ALKAMIDES; PREGNANCY; PREGNANCY COMPLICATIONS; RECEPTORS, CANNABINOID;

EID: 33746669402     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28621     Document Type: Article

References (58)

1. Farquhar, C.M. 2005. Ectopic pregnancy. Lancet. 366:583-591.
2. Devane, W.A., et al. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1946-1949.
3. Mechoulam, R., et al. 1995. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50:83-90.
4. Sugiura, T., et al. 1995. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215:89-97.
5. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., and Bonner, T.I. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:561-564.
6. Munro, S., Thomas, K.L., and Abu-Shaar, M. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:61-65.
7. Paria, B.C., Das, S.K., and Dey, S.K. 1995. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 92:9460-9464.
8. Wang, H., et al. 2004. Aberrant cannabinoid signaling impairs oviductal transport of embryos. Nat. Med. 10:1074-1080.
9. Paria, B.C., et al. 2001. Dysregulated cannabinoid signaling disrupts uterine receptivity for embryo implantation. J. Biol. Chem. 276:20523-20528.
10. Wang, H., et al. 2003. Differential G protein-coupled cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation. Proc. Natl. Acad. Sci. U. S. A. 100:14914-14919.
11. Di Marzo, V., et al. 1994. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature. 372:686-691.
12. Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., and Ueda, N. 2004. Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279:5298-5305.
13. Cravatt, B.F., et al. 1996. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 384:83-87.
14. Compton, W.M., Grant, B.F., Colliver, J.D., Glantz, M.D., and Stinson, F.S. 2004. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA. 291:2114-2121.
15. Hall, W., and Solowij, N. 1998. Adverse effects of cannabis. Lancet. 352:1611-1616.
16. Feng, T. 1993. Substance abuse in pregnancy. Curr. Opin. Obstet. Gynecol. 5:16-23.
17. Gaoni, Y., and Mechoulam, R. 1964. Isolation, structure, and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86:1646-1647.
18. Bisogno, T., et al. 2001. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br. J. Pharmacol. 134:845-852.
19. Hanus, L.O., et al. 2005. Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors. Org. Biomol. Chem. 3:1116-1123.
20. Lagu, S.G., Varona, A., Chambers, J.D., and Reggio, P.H. 1995. Construction of a steric map of the binding pocket for cannabinoids at the cannabinoid receptor. Drug Des. Discov. 12:179-192.
21. Psychoyos, A. 1973. Endocrine control of egg implantation. In Handbook of physiology. R.O. Greep and E.B. Astwood, editors. American Physiological Society. Washington, DC, USA. 187-215.
22. Paria, B.C., Huet-Hudson, Y.M., and Dey, S.K. 1993. Blastocyst's state of activity determines the "window" of implantation in the receptive mouse uterus. Proc. Natl. Acad. Sci. U. S. A. 90:10159-10162.
23. Wang, J., Paria, B.C., Dey, S.K., and Armant, D.R. 1999. Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development. Biol. Reprod. 60:839-844.
24. Guo, Y., et al. 2005. N-acylphosphatidylethanolamine-hydrolyzing phospholipase D is an important determinant of uterine anandamide levels during implantation. J. Biol. Chem. 280:23429-23432.
25. Kathuria, S., et al. 2003. Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med. 9:76-81.
26. Cravatt, B.F., and Lichtman, A.H. 2002. The enzymatic inactivation of the fatty acid amide class of signaling lipids. Chem. Phys. Lipids. 121:135-148.
27. Strumpf, D., et al. 2005. Cdx2 is required for correct cell fate specification and differentiation of trophectoderm in the mouse blastocyst. Development. 132:2093-2102.
28. Niwa, H., et al. 2005. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell. 123:917-929.
29. Meissner, A., and Jaenisch, R. 2006. Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature. 439:212-215.
30. Mitsui, K., et al. 2003. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 113:631-642.
31. Chambers, I., et al. 2003. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 113:643-655.
32. Nichols, J., et al. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 95:379-391.
33. Niwa, H., Miyazaki, J., and Smith, A.G. 2000. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24:372-376.
34. Das, S.K., et al. 1994. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development. 120:1071-1083.
35. Wang, H., and Dey, S.K. 2006. Roadmap to embryo implantation: clues from mouse models. Nat. Rev. Genet. 7:185-199.
36. Song, H., et al. 2002. Cytosolic phospholipase A2alpha is crucial for 'on-time' embryo implantation that directs subsequent development. Development. 129:2879-2889.
37. Ye, X., et al. 2005. LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature. 435:104-108.
38. Wilcox, A.J., Baird, D.D., and Weinberg, C.R. 1999. Time of implantation of the conceptus and loss of pregnancy. N. Engl. J. Med. 340:1796-1799.
39. Maccarrone, M., et al. 2002. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol. Hum. Reprod. 8:188-195.
40. Maccarrone, M., et al. 2000. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet. 355:1326-1329.
41. Di Marzo, V., Bifulco, M., and De Petrocellis, L. 2004. The endocannabinoid system and its therapeutic exploitation. Nat. Rev. Drug Discov. 3:771-784.
42. Cravatt, B.F., et al. 2001. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. U. S. A. 98:9371-9376.
43. Schuel, H., et al. 2002. Evidence that anandamide-signaling regulates human sperm functions required for fertilization. Mol. Reprod. Dev. 63:376-387.
44. Schuel, H., and Burkman, L.J. 2005. A tale of two cells: endocannabinoid-signaling regulates functions of neurons and sperm. Biol. Reprod. 73:1078-1086.
45. Maccarrone, M., et al. 2005. Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction. J. Cell Sci. 118:4393-4404.
46. Rossato, M., Ion Popa, F., Ferigo, M., Clari, G., and Foresta, C. 2005. Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J. Clin. Endocrinol. Metab. 90:984-991.
47. Cobellis, G., et al. 2006. Endocannabinoid system in frog and rodent testis: type-1 cannabinoid receptor and fatty acid amide hydrolase activity in male germ cells. Biol. Reprod. doi:10.1095/biolreprod.106.051730.
48. Centers for Disease Control and Prevention. 1995. Ectopic pregnancy - United States, 1990-1992. MMWR Morb. Mortal. Wkly. Rep. 44:46-48.
49. Lichtman, A.H., Shelton, C.C., Advani, T., and Cravatt, B.F. 2004. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia. Pain. 109:319-327.
50. Bifulco, M., and Di Marzo, V. 2002. Targeting the endocannabinoid system in cancer therapy: a call for further research. Nat. Med. 8:547-550.
51. Guzman, M. 2003. Cannabinoids: potential anticancer agents. Nat. Rev. Cancer. 3:745-755.
52. Chiang, K.P., Gerber, A.L., Sipe, J.C., and Cravatt, B.F. 2004. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum. Mol. Genet. 13:2113-2119.
53. Sipe, J.C., Chiang, K., Gerber, A.L., Beutler, E., and Cravatt, B.F. 2002. A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc. Natl. Acad. Sci. U. S. A. 99:8394-8399.
54. Castellano, C., Ventura, R., Cabib, S., and Puglisi-Allegra, S. 1999. Strain-dependent effects of anandamide on memory consolidation in mice are antagonized by naltrexone. Behav. Pharmacol. 10:453-457.
55. Hoffman, A.F., Macgill, A.M., Smith, D., Oz, M., and Lupica, C.R. 2005. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus. Eur. J. Neurosci. 22:2387-2391.
56. Shinohara, O., Henrich, R.T., and Morishima, A. 1983. Effects of chronic administration of delta-9-tetrahydrocannabinol on early embryogenesis of the mouse. Biol. Reprod. 29:663-670.
57. Paria, B.C., Kapur, S., and Dey, S.K. 1992. Effects of 9-ene-tetrahydrocannabinol on uterine estrogenicity in the mouse. J. Steroid Biochem. Mol. Biol. 42:713-719.
58. Paria, B.C., et al. 1998. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol. Reprod. 58:1490-1495.